Julie O’Neill has been a member of DBV’s Board of Directors since 2017. She was formerly Executive Vice President, Global Operations for Alexion Pharmaceuticals Inc, responsible for global process development & manufacturing, as well as the company’s supply chain, quality and real estate operations. Before joining Alexion, she was Vice President of Operations and General Manager for Ireland at Gilead Sciences, Inc. Earlier in her career, Ms. O’Neill held leadership positions in operations,
manufacturing and quality functions within the pharmaceutical industry.